This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider literature (EMCDDA)
Bibliography: All Publications
What is drug policy evaluation and why is it important?
To support those considering or involved in commissioning, managing or undertaking policy evaluations, this provides access to a range of materials, including a 7-step guide, examples of strategies and evaluations in Europe and potentially useful data sources (EMCDDA)
EMCDDA Treatment demand indicator (TDI)/treatment expert meeting
Documents now available for download (EMCDDA)
The Evaluation of the Drug Recovery Wing Pilots (PDF)
In 2012, the Department of Health commissioned an evaluation of these pilots, which has been undertaken by researchers at the University of York, the Centre for Drug Use Research in Glasgow and the University of Cambridge
The opioid crisis in north America (PDF)
To mitigate the current crisis, the Global Commission on Drug Policy recommends:
Evaluation of the Drugs and Alcohol Recovery Payment by Results Pilot Programme Final Report (PDF)
Findings in this report from the process evaluation have been subject to RAND Europe’s interim quality assurance review. The report was completed in September 2015 and is based on data collected up to March 2014 (National Drug Evidence Centre)
Acryloylfentanyl to be placed under control across the EU
This week, the EU has reacted to serious concerns over the use of the synthetic opioid acryloylfentanyl by deciding to subject it to ‘control measures’ throughout the Union (EMCDDA)
The case for a national prescribed drug helpline (PDF)
All Party Parliamentary Group for Prescribed Drug Dependence
Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2014/15: Sweep 11 report (PDF)
This report presents the findings of Sweep 11 of the estimates of the prevalence of opiate and/or crack cocaine use (OCU) in England, covering 2014/15. These continue the long time series of OCU prevalence estimates, starting in 2004/05 and most recently reported for 2011/12 (PHE)
National Drug Strategy Household Survey 2016: detailed findings
… certain groups disproportionately experience drug-related risks and recent use of illicit drugs was particularly high for people who identified as homosexual or bisexual (AIHW)
Drug induced deaths at highest rate since late 90s
Australia recorded the highest number of drug-induced deaths since the late 1990s, with the death rate steadily increasing over a decade and now at 7.5 deaths per 100,000 Australians (Australian Bureau of Statistics)
Dealing with Synthetics: Time to Reframe the Narrative (PDF)
Beginning with an overview of the synthetics market, this Policy Report examines the possible sources of such inertia and critically explores the issues underlying what in many respects represents a key yet largely under discussed feature of the extant international drug control system (GDPO)
Psychoactive substances in secure mental health settings
This review summarises the latest evidence and makes recommendations for secure mental health service commissioners and providers (Public Health England)
Charter for Change
Ten points from The Drugs, Alcohol & Justice Cross-Party Parliamentary Group
A model drug law to 2020 and beyond
The key to moving towards an Aotearoa free from drug harm is to start treating drug use as a health issue rather than a criminal issue. Download (New Zealand Drug Foundation)
EMCDDA signs accord with Swiss Federal Office of Public Health
The two bodies recognise that information on the drug phenomenon is an essential and indispensable instrument for drafting and implementing drug policies and for assessing the impact of actions to reduce problems originating from drug use and trafficking
Key Substance Use and Mental Health Indicators in the United States
Results from the 2016 National Survey on Drug Use and Health (SAMHSA)
Deaths by drug poisoning where any opiates were mentioned on the death certificate, local authorities in England and Wales, 1993 to 2016
Office for National Statistics UK – link to Excel file
Provisional Drug Overdose Deaths 2016 – 2017 (PDF)
These counts include all seasons of the year and are insensitive to reporting variations by seasonality. Deaths are reported by the jurisdiction in which the death occurred (CDC)
Commissioning impact on drug treatment
This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment
National Poisons Information Service Report 2016/17
National Poisons Information Service annual report with section on drugs of misuse (PDF)
Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (PDF)
The Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 (the Bill) seeks to amend the Drugs, Poisons and Controlled Substances Act 1981 (the Principal Act), to provide for the licencing and operation of a medically supervised injecting centre (MSIC) for a trial period of 18 months (Parliament of Victoria, Australia)
Annual Surveillance Report of Drug-Related Risks and Outcomes (PDF)
The purpose of this first annual surveillance report is to summarize the latest information available on the national level for various health outcomes, health behaviors, and prescribing patterns related to the drug problem in the United States (CDC, USA)
ACMD warns ministers of falling local funding for drug treatment services
Funding cuts are the single biggest threat to drug treatment recovery outcomes, a report published by the ACMD has warned
Still no harm reduction? (PDF)
A critical review of the UK Government’s new Drug Strategy (drugscience)
Mapping the Maze (PDF)
Services for women experiencing multiple disadvantage in England and Wales (agenda)
Widening the availability of naloxone
Updated 1 August 2017 (DoH)
Improving clinical responses to drug-related deaths (PDF)
A summary of best practice and innovations from drug treatment providers (NHS Substance Misuse Provider Alliance)
Drug driving law evaluation
Evaluation of the new drug driving legislation, one year after its introduction (Department for Transport)
Drug-related deaths in Scotland, 2016
Numbers of drug-deaths in Scotland by (e.g.) age, sex, Health Board and council areas, and whether particular drugs were in the body (National Records of Scotland)
Hepatitis C Screening (PDF)
National Clinical Guideline (Irish Government)
3.1.4 People who use unprescribed or illicit drugs
3.1.5 Prisoners
3.1.6 People who are homeless
Preventing drug related deaths (PDF)
Drug-related deaths are rising and are a major concern to councils and our health partners. Deaths have increased sharply over the past five years and are now at their highest levels since records began. The reasons for the jump are varied. When Public Health England (PHE) and the Local Government Association (LGA) investigated it last year they came to a number of conclusions
Interim report prepared by White House Commission on Combating Drug Addiction and the Opioid Crisis
Recommendations for action (White House)
Drug Related Deaths in Scotland
This describes a study that involved age-period-cohort analyses to investigate whether cohort effects from exposure to the changing political context from the 1980s could explain the recent trends in drug-related deaths in Scotland (OSF)
Deaths related to drug poisoning in England and Wales: 2016 registrations
Latest update on deaths related to drug poisoning in England and Wales by cause of death, sex, age and substances involved in the death. A backseries of data from 1993 is also included in this publication (Office of National Statistics)
Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report
This article presents an overview of the trends between 2006 and 2016 for HIV, hepatitis B, hepatitis C and risk behaviours from the main Unlinked Anonymous Monitoring Survey, which is targeted at people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines (Public Health England)
Take-home naloxone for opioid overdose in people who use drugs
Advice for local authorities and local partners on widening the availability of naloxone to reduce overdose deaths from heroin and other opiate drugs (Public Health England)
Widening the availability of naloxone
Naloxone is a prescription-only medicine and cannot therefore be sold over the counter. It can however be supplied without prescription by drug services. It can be used by anyone to save a life in an emergency (DoH)
Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States (National Academy of Sciences.)
The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
This study produced 20 research recommendations on novel psychoactive substance use, for researchers and research commissioners to use in developing the public health evidence-base (NIHR)
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 49
- Next Page »
